Brief: Aft Pharmaceuticals Says US FDA Approved Rapid Release Tablet Form Of Maxigesic
01/03/2023 22:57
March 2 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* US FDA APPROVED RAPID RELEASE TABLET FORM OF MAXIGESIC FOR
MANAGEMENT OF MILD TO MODERATE ACUTE PAIN
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV